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Ventricular Filling in Hypertrophic Cardiomyopathy:
Effect of Verapamil
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Left ventricular relaxation and filling are impaired in
many patients with hypertrophic cardiomyopathy. To
investigate the influence of regionalheterogeneity on these
global abnormalities, 48 patients with hypertrophic car-
diomyopathy and sinus rhythm were studied by radio-
nuclide angiography before and after 1 to 2 weeks of
verapamil therapy (320to 640mg/day, median 480). Left
ventricular regional function was assessed by subdivid-
ing the ventricular region of interest into 20 sectors and
into four quadrants from which regional time-activity
curves were derived. Diastolicasynchrony was measured
as the regional variation in timing between minimal vol-
ume and peak filling rate, and heterogeneity in the mag-
nitude of rapid diastolic filling was measured as the re-
gional variation in percent contribution of atrial systole
to end-diastolic volume.
Left ventricular diastolic function is impaired in many pa-
tients with hypertrophic cardiomyopathy (1-6). Reduced
rate and magnitude of left ventricular rapid diastolic filling
in this disease reflect not only decreased left ventricular
distensibility (7-11) arising from hypertrophy, fibrosis or
cellular disorganization, but also disturbances in active left
ventricular relaxation (1-4,12,13). Numerous studies (14-24)
of ischemic heart disease have demonstrated that global left
ventricular relaxation may be prolonged or incomplete in
the setting of nonuniform regional left ventricular function
arising from segmental ischemia or fibrosis. However, the
relation between spatial and temporal nonuniformity and
impaired global ventricular diastolic filling has not been
studied extensively in hypertrophic cardiomyopathy, and the
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Compared with 28 normal subjects, the patients with
hypertrophic cardiomyopathy had greater regional vari-
ation in both timing (35 ± 24 versus 12 ± 6 ms, p <
0.001) and magnitude (10 ± 6 versus 7 ± 4%, P <
0.02) of rapid filling. Verapamil reduced the regional
variation in timing (to 21 ± 16 ms, p < 0.001) and
magnitude (to 7 ± 3%, P < 0.001)of rapid filling. These
regional changes, indicating more uniform regional di-
astolic performance after verapamil, were associated with
improved global diastolic filling: global rapid filling in-
creased in both rate and magnitude and time to peak
filling rate decreased. These findings indicate that the
beneficial effectof verapamil on left ventricular diastolic
function in hypertrophic cardiomyopathy may be me-
diated by reduction in regional asynchrony.
(J Am Coil Cardiol1987;9:1108-16)
potential for reversal of regional heterogeneity during med-
ical therapy in this disease has not been addressed.
In our study, we evaluated regional left ventricular asyn-
chrony and its relation to global left ventricular filling in
patients with hypertrophic cardiomyopathy using radio-
nuclide angiography. Because oral verapamil enhances left
ventricular relaxation and filling in such patients (5,6,25-27),
we also studied the effect of verapamil on regional left
ventricular asynchrony in relation to changes in global ven-
tricular diastolic filling.
Methods
Patient selection. We studied 48 patients with hyper-
trophic cardiomyopathy by radionuclide angiography before
and after they underwent I to 2 weeks of verapamil therapy.
Patients ranged in age from 21 to 69 years (mean 43); there
were 29 men and 19 women. In each patient, the diagnosis
of hypertrophic cardiomyopathy was based on M-mode or
two-dimensional echocardiographic confirmation of a hy-
pertrophied, nondilated left ventricle in the absence of an-
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other cardiac or systemic disease capable of causing myo-
cardial hypertrophy (28). Cardiac catheterization in 46 patients
demonstrated a rest subaortic pressure gradient of 2:30 mm
Hg in 18 patients (37%), a provocable gradient during the
Valsalva maneuver, amyl nitrite inhalation or intravenous
isoproterenol infusion in 18 (37%) and no rest or provocable
gradient in 10 (21%). The two patients who were not cath-
eterized manifested marked systolic anterior motion of the
anterior mitral valve leaflet on echocardiography, compat-
ible with a rest outflow tract gradient (29). All patients were
limited by moderate to severe symptoms of angina, exer-
tional dyspnea, orthopnea or paroxysmal nocturnal dyspnea
(New York Heart Association functional class III to IV).
All had normal sinus rhythm. Concomitant coronary artery
disease was excluded in 33 patients by coronary arteriog-
raphy; 31 of these patients had completely normal arterio-
grams and 2 had only mild coronary atherosclerosis «50%
reduction in luminal diameter). Of the 15 patients who did
not undergo coronary arteriography, 13 were <40 years of
age (6 were ::;30); the other 2 patients were <45 years and
did not report angina pectoris. Forty-three of the 48 patients
were included in a previous study demonstrating the relation
between improved left ventricular filling during verapamil
therapy and increased exercise tolerance (27).
Patients were included in this study under guidelines of
protocols 77-H-156 and 80-H-65 approved by the Clinical
Research Subpanel of the National Heart, Lung, and Blood
Institute on September 2, 1977 and June 23, 1980, respec-
tively. All patients gave written informed consent. The ra-
diation exposure from a single radionuclide angiogram is
estimated to be 0.357 rad (total body dose).
Verapamil administration. Radionuclide angiography
was performed at least 48 hours after cessation of propran-
olol and all other cardiac medications. No patient had been
receiving other beta-adrenergic blocking agents before en-
tering this study, and no patient had been treated previously
with verapamil. After baseline studies were complete, ve-
rapamil was administered orally, beginning at 240 to 320
mg/day in divided doses. The dose was increased gradually
every 36 to 48 hours as tolerated, to a target dose of 480
mg/day. The final dosage was determined by the clinical
response of each patient and was limited in some patients
because of atrioventricular (AV) dissociation, Mobitz type
I second degree AV block or systemic hypotension. The
final daily verapamil dose was 320 mg in 9 patients, 360
mg in II, 480 mg in 26 and 640 mg in 2. Radionuclide
angiography was repeated after each patient received what
was considered to be the optimal dose for at least 36 hours.
Gated Blood Pool Cardiac Scintigraphy
Data acquisition. Radionuclide angiography was per-
formed at rest with patients in the supine position using red
blood cells labeled in vivo with 15 to 20 mCi of technetium-
99m and a conventional Anger camera equipped with a high
sensitivity, parallel-hole collimator oriented in a modified
left anterior oblique position. A total of 7.5 to 10.5 million
counts was acquired for each study. High temporal reso-
lution (10 to 20 ms/frame) cardiac image sequences were
constructed by computer-based electrocardiographic (ECG)
gating, with the use of list-mode data acquisition with ex-
clusion of extrasystolic and postextrasystolic cycles and
combined forward and reverse gating from the R wave (5,30).
Left ventricular time-activity curves, representing relative
changes in left ventricular volume during the average cardiac
cycle, were generated from the cardiac image sequence after
background correction with a fixed left ventricular region
of interest, which was constructed manually to conform to
the borders of the left ventricle as identified from the end-
diastolic image, the stroke volume image and the amplitude
image. This latter functional image was created by approx-
imating each single-pixel time-activity curve with the first
harmonic of its temporal Fourier expansion (31). After the
region of interest was identified in this manner, the time-
activity curve was constructed from the raw image sequence
without spatial or temporal smoothing processes.
Analysis of global left ventricular function. Indexes
of global left ventricular function were derived by computer
analysis of the background-corrected time-activity curve.
Ejection fraction was computed on the basis of relative end-
diastolic and end-systolic counts. Peak left ventricular ejec-
tion and filling rates were determined by fitting third order
polynomial functions to the systolic ejection and rapid di-
astolic filling portions of the time-activity curve by a least
squares technique (5). The time of occurrence of the peak
ejection or peak filling rate was obtained by setting the
second derivative of the polynomial function to zero. Time
to peak ejection rate was measured from the R wave and
time to peak filling rate was measured relative to end-systole
(minimal volume on the time-activity curve). Both peak
ejection rate and peak filling rate were computed in left
ventricular counts/s, normalized for the number of counts
at end-diastole and expressed as fractional end-diastolic counts
(or end-diastolic volume)/s (EDV/s). When normalized for
end-diastolic volume, both peak ejection rate and peak fill-
ing rate are influenced inversely by the magnitude of end-
diastolic volume and directly by the magnitude of the ejec-
tion fraction (32,33). Because patients with hypertrophic
cardiomyopathy as a group have reduced end-diastolic vol-
ume and a supranormal ejection fraction, comparison of the
filling rate data between these patients and normal subjects
is difficult. To minimize this effect, we also analyzed peak
filling rate using two additional normalization methods: peak
filling rate was expressed relative to left ventricular stroke
volume (SV/s) and as the ratio of peak filling rate to peak
ejection rate (22,34). These two latter methods have the
additional advantage of being background independent.
We also determined the contribution of atrial systole to
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left ventricular filling volume and end-diastolic volume in
44 of the 48 patients. This additional analysis could not be
performed in four patients because a definite diastasis in-
terval separating rapid diastolic filling from atrial systole
was not evident on the time-activity curve, and hence the
contribution of atrial systole could not be differentiated from
that of rapid filling. In the 44 patients in whom diastasis
was observed, the onset of atrial systole was determined as
previously described (6). The total duration of the PR in-
terval (onset of P wave to onset of QRS complex) plus the
interval from the QRS onset to the instant of R wave gating
(peak negative R to S transition) was measured to the nearest
20 ms from an ECG rhythm strip obtained during the radio-
nuclide data acquisition. This sum was subtracted from the
cardiac cycle length to indicate the point on the time-activity
curve representing the onset of electrical atrial activation;
40 ms was added to this value to account for atrial electro-
mechanical delay, and this new point on the curve was
chosen as the onset of mechanical atrial systole (6). Relative
left ventricular filling during atrial systole was then com-
puted as a percent of total left ventricular stroke volume
and left ventricular end-diastolic volume. A three point (that
is, 60 ms) average was performed about the point on the
curve selected as the onset of atrial systole to minimize the
influence of random noise.
In addition to these indexes describing global left ven-
tricular function, we also analyzed relative regional left
ventricular asynchrony by sector analysis (22,35). This was
accomplished by dividing the left ventricular region of in-
terest first into 20 sectors and then into four quadrants.
Sector analysis. The left ventricular region of interest
was divided into 20 sectors of equal arc (18°), each ema-
nating from the end-diastolic left ventricular center of grav-
ity. The inner one-third of each sector was then excluded,
yielding annular sectors constituting the outer two-thirds of
the left ventricle (35). From these fixed regions, sectorial
time-activity curves were generated, representing the change
in counts within each sector during the average cardiac
cycle. From these data, we computed an index of regional
systolic asynchrony and an index of regional homogeneity
in the extent of rapid diastolic filling.
The index of regional systolic asynchrony was obtained
by describing each sector time-activity curve by a two-
harmonic Fourier expansion. The nadir of this curve was
used to approximate the time to minimal volume (measured
from the R wave) of each sector. The variation in time to
minimal volume among sectors was assessed quantitatively
as the standard deviation about the mean value for the 20
sectors (22).
The index of regional homogeneity of rapid filling was
determined as the variation among sectors in relative filling
during atrial systole in the 44 patients in whom it was pos-
sible to assess the contribution of atrial systole in the global
time-activity curve. For these regional measurements, the
volume filled during atrial systole for each sector was com-
puted as a percent of the end-diastolic volume of that sector,
using the same method used to compute the contribution of
atrial systole to global filling volume. The regional variation
in percent filling during atrial systole was then assessed, as
with the time to minimal volume data, by computing the
standard deviation about the mean value of the 20 sectors.
Because there is an excellent inverse relation between the
percent of left ventricular volume filled during atrial systole
and the percent filled during the rapid filling period (6), we
used the regional variation in contribution of atrial systole
to reflect regional heterogeneity in the magnitude of rapid
diastolic filling.
Quadrant analysis. Computation of more specific tem-
poral indexes from the 20 sector time-activity curves, such
as time to peak ejection rate or time to peak filling rate,
was not possible because of the limited precision of mea-
surement caused by counting f1uctations in each sector curve,
resulting in large errors in the measurement of these specific
intervals. To improve the precision and reduce the errors in
these specific regional temporal measurements, we created
quadrants by combining the 20 sectors into four quadrants
of 5 sectors each (22). Regional time-activity curves were
then generated from each quadrant, which were then fit to
a Fourier expansion with three harmonics (36). From the
fitted curve, the time to peak ejection rate, time to minimal
volume and time to peak filling rate were computed. Time
to peak ejection rate and time to minimal volume were
measured from the R wave, whereas time to peak filling
rate, as in the global volume curve, was expressed relative
to each quadrant's time to minimal volume. From each of
the fitted quadrant curves, we also computed the extent of
left ventricular filling during atrial systole as a percent of
end-diastolic volume. To assess the regional variation in
each of these variables, the absolute value of the difference
between the global value and the value for each of the four
quadrants was calculated, and these four differences were
then averaged (22).
Reproducibility of regional measurements. Repro-
ducibility of the regional data obtained from sector and
quadrant analyses were determined in 25 patients with hy-
pertrophic cardiomyopathy. In these patients, two radio-
nuclide angiographic data acquisitions were obtained at rest
after withdrawal from all cardioactive medicines. From these
duplicate studies, confidence limits for reproducibility of
each variable were determined as the mean difference plus
2 SD. The reproducibility limit for the regional variation
measurements by sector analysis was 22 ms for time to
minimal volume and 8% for regional filling during atrial
systole. These limits for regional variation by quadrant anal-
ysis were 8 ms for time to peak ejection rate, 11 ms for
time to minimal volume, 12 ms for time to peak filling rate
and 6% for regional filling during atrial systole. Reproduc-
ibility limits for measurements of global left ventricular
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function in these 25 patients have been reported previously
(6).
Normal data. The normal values for indexes of global
left ventricular function and regional left ventricular asyn-
chrony have been presented previously (22) in 28 asymp-
tomatic normal subjects without any evidence of cardio-
vascular disease on the basis of history, blood pressure,
physical examination, echocardiogram and chest X-ray film.
These subjects ranged in age from 31 to 60 years (mean
46) and were used again in our study as a control group.
The data in these subjects were obtained during the same
time period as were the data in the hypertrophic cardio-
myopathy patients and were analyzed by the same technical
staff. To complete the normal data base for our investiga-
tion, we analyzed the contribution of atrial systole to left
ventricular filling volume for the global, sector and quadrant
time-activity curves in 25 of the 28 subjects. Three subjects
were excluded from this particular analysis because a def-
inite diastasis interval separating rapid diastolic filling from
atrial systole was not evident. The regional variation in
magnitude of left ventricular filling during atrial systole was
then computed as in the patients with hypertrophic cardio-
myopathy.
Echocardiography
The radionuclide angiographic data pertaining to regional
left ventricular function were compared with regional mor-
phologic data obtained by two-dimensional echocardiog-
raphy in 39 of the 48 patients. A Varian (V-3000 or V-
3400) real-time, phased array, ultrasound sector scanner
with a hand-held 2.25 MHz transducer, or an Advanced
Technology Laboratory (ATL) Mark 500 mechanical sector
scanner (84°) with a 3 MHz transducer was used to perform
the echocardiographic studies. Images were recorded on
either a 0.5 inch (1.27 em) (Sanyo) cassette videotape or I
inch (2.54 em) (Sony) reel to reel videotape for subsequent
review in real-time, slow motion or stop action mode. Two-
dimensional echocardiographic examination included im-
ages obtained in the parasternal long-axis and multiple short-
axis views, as well as apical two and four chamber views
using standard transducer positions (37).
The technical quality of the echocardiographic studies
permitted reliable assessment of the extent and distribution
of left ventricular hypertrophy in 33 of the 39 patients. For
purposes of our study, the presence and magnitude of hy-
pertrophy involving the basal and apical portions of the
ventricular septum and posterolateral free wall and the left
ventricular apex were assessed by two-dimensional echo-
cardiography (38) and were compared with data obtained
from corresponding regions of the left ventricle by radio-
nuclide angiography. Echocardiographic analysis was per-
formed without knowledge of the radionuclide angiographic
results.
Statistical methods. Comparison between normal sub-
jects and the patients with hypertrophic cardiomyopathy was
performed with the t test for unpaired data. Linear regression
analysis was used to test the relation between the regional
indexes of asynchrony and global indexes of diastolic filling,
and between the regional indexes of asynchrony and the
magnitude of the left ventricular outflow gradient measured
at catheterization. Changes from before to after verapamil
were analyzed with the t test for paired data.
Results
Global left ventricular function. Under control con-
ditions, both left ventricular ejection fraction and peak!left
ventricular ejection rate were elevated in the patients with
hypertrophic cardiomyopathy compared with the normal
subjects (Table I). Time to minimal volume was prolonged
in the patients with hypertrophic cardiomyopathy, reflecting
prolongation of systolic ejection in patients with an outflow
tract gradient (13,39); time to minimal volume in the 10
patients without outflow obstruction (327 ± 26 ms) was
significantly shorter than that of either the 18 patients with
rest outflow obstruction (389 ± 35 ms, p < 0.001) or the
18 patients with provocable obstruction (370 ± 46 ms,
p < 0.01).
Left ventricular rapid diastolic filling was impaired in
the patients with hypertrophic cardiomyopathy. Although
the peak rate of left ventricular filling was not different from
that of the normal subjects when normalized to end-diastolic
volume (Table I), it was significantly less than normal when
normalized to left ventricular stroke volume or expressed
as the ratio of peak filling to peak ejection rate (thereby
minimizing the influence of reduced end-diastolic volume
or supranormal ejection fraction [34]). Moreover, time to
peak filling rate was prolonged and the contribution of atrial
systole to left ventricular filling volume was increased com-
pared with normal. None of the diastolic filling variables
differed among patients with regard to the presence or se-
verity of outflow tract gradients.
Regional left ventricular asynchrony. The global ab-
normalities of diastolic filling in patients with hypertrophic
cardiomyopathy were associated with significant systolic
and diastolic asynchrony: the regional variation in both time
to minimal volume and time to peak filling rate was greater
than normal (Table 1, Fig. 1). The regional variation in
time to peak filling rate (the index of diastolic asynchrony)
correlated with global peak filling rate (r = 0.43, P < 0.01),
No such correlation was observed between indexes
of systolic asynchrony and global filling variables. No index
of regional asynchrony correlated with the presence or se-
verity of an outflow tract gradient or with the prolongation
of global time to minimal volume.
Regional variation in contribution of atrial systole.
The diastolic asynchrony in the patients with hypertrophic
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Table 1. Variables Describing Global and Regional Left Ventricular Function
Heart rate (beats/min)
Systemic blood pressure (mm Hg)
Systolic
Diastolic
Global LV systolic function
LV ejection fraction (%)
Peak LV ejection rate (EDV/s)
Time to minimal LV volume (ms)
Global LV diastolic filling
Peak LV filling rate
EDV/s
SV/s
PFR/PER
Time to peak filling rate (ms)
Contribution of atrial systole*
% of ED\'
% of SV
Regional LV asynchrony
Variation among 20 sectors
Time to minimal volume (ms)
Variation among four quadrants
Time to peak ejection rate (ms)
Time to minimal volume (ms)
Time to peak filling rate (ms)
Regional filling during atrial systole*
Variation among 20 sectors (% of EDV)
Variation among four quadrants (% of EDV)
Normal Patients With HCM
Subjects (n = 48)
(n = 28) Control Verapamil p Value
71 ± 12 70 ± II 67 ± 9t <0.01
122 ± II 116 ± 18 114 ± 14:1: NS
76 ± 8 67 ± 12 68 ± II NS
56 ± 7 75 ± IO§ 75 ± 9§ NS
3.1 ± 0.6 3.9 ± 0.7§ 3.9 ± 0.6§ NS
341 ± 31 367 ± 43:1: 360 ± 30t NS
3.3 ± 0.6 3.3 ± l.l 4.3 ± 1.3§ <0.001
5.7 ± 1.1 4.5 ± 1.4§ 5.8 ± 1.6 <0.001
1.09 ± .25 0.87 ± .3U 1.13 ± .35 <0.001
150 ± 18 189 ± 43§ 170 ± 29§ <0.005
10 ± 4 23 ± 13§ 13 ± 7 <0.001
17 ± 6 30 ± 17§ 16 ± 9 <0.001
19 ± 6 34 ± 15 24 ± 10 <0.001
13 ± 4 18 ± 12t 16 ± 12 NS
10 ± 6 25 ± 19 15 ± 4:1: <0.005
12 ± 6 35 ± 24 21 ± 16 <0,001
6 ± I II ± 4 10 ± 4 <0.05
7 ± 4 10 ± 6t 7 ± 3 <0.001
*Measured in patients with distinct diastasis interval (25 normal subjects and 44 patients with hypertrophic cardiomyopathy). Statistical difference
compared with normal subjects: tp <0.05; :l:p <0.01; §p <0.001. Data are mean ± SD. EDV = end-diastolic volume; HCM = hypertrophic
cardiomyopathy; LV = left ventricular; PFR/PER = peak filling rate/peak ejection rate ratio; SV = stroke volume.
cardiomyopathy was associated with greater regional het-
erogeneity in the magnitude of rapid diastolic filling com-
pared with normal, manifested by greater variation in the
contribution of atrial systole to regional end-diastolic vol-
ume by both sector and quadrant analysis (Table I, Fig. 1
and 2). A weak but significant correlation was observed
between the regional variation in contribution of atrial sys-
tole and global peak filling rate (r = 0.41, P < 0.01).
Localization of asynchronous regions. The regional
variation in contribution of atrial systole was analyzed on
Figure 1. Global (top) and quadrant (bottom) time-
activity curves in a normal subject and a patient
with hypertrophic cardiomyopathy. The global data
demonstrate reduced rate and extent of rapid filling,
prolonged time to peak filling rate and increased
contribution of atrial systole (AS) in the patient with
hypertrophic cardiomyopathy. Vertical lines indi-
cate global time to minimal volume (TMV) and time
to peak filling rate (TPFR), and short vertical bars
indicate these times in each quadrant curve. Systolic
and diastolic synchrony are evident in the normal
subject, whereas the patient with hypertrophic car-
diomyopathy manifests diastolic asynchrony and re-
gional variation in the relative magnitude of rapid
filling and atrial systole. EDV = end-diastolic vol-
ume; LV = left ventricular.
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SECTOR NUMBER
Figure 2. Contribution of atrial systole to end-diastolic volume
for each of 20 sectors in three patients (A, B and C) with hyper-
trophic cardiomyopathy (HCM) compared with normal subjects of
matched heart rate (HR). The contributions of atrial systole to
global end-diastolic volume are shown in the right portion ofeach
panel. Lat = lateral.
a sector by sector basis for each patient (Fig. 2). In each
study, regions with accentuatedcontributionof atrial systole
compared with other regions of the left ventricle were as-
sessed qualitatively and tabulated. Sectors with augmented
filling during atrial systole were localized to the ventricular
septum or to the septum and left ventricular apex in 14
patients (Fig. 2A), involved both the septum and postero-
lateral wall in 24 (Fig. 2B) and were confined to the lateral
wall in 3. In the remaining seven patients, there was ap-
parently homogeneous regional filling in that no localized
region of increased contribution of atrial systole could be
identified.
Of the 33 patients in whom two-dimensional echocar-
diographic and radionuclide angiographic correlations were
available. the localizationof regionswith accentuatedfilling
during atrial systole corresponded to the distribution of left
ventricular hypertrophy in 18 patients. Among the other 15
patients, in whom regional radionuclide angiographic and
echocardiographic data were discordant, the radionuclide
angiographic results in II patients indicated accentuated
filling during atrial systole in severelyhypertrophied regions
but also in regions of the left ventricle that did not appear
to be substantially hypertrophied by echocardiography.
Effect of verapamil. Verapamil did not affect indexes
of global left ventricularsystolicfunction (Table I): ejection
fraction, peak ejection rate and time to minimal volume
were not altered during drug therapy. Despite a significant
decreasein heart rate, indexesof globalrapiddiastolicfilling
improvedduring verapamiltherapy, as previouslydescribed
(5,6,27): peak filling rate increased and the magnitude of
filling during atrial systole decreased, reflecting an increase
in the contribution of rapid filling to global left ventricular
diastolic and stroke volumes. Verapamil also reduced the
severityof regional systolic and diastolic asynchrony (Table
HCM HR 77
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Figure 3. Variation among quadrants in time to min-
imal volume (TMV) and time topeak filling rate (TPFR)
before (Control) and after verapamil therapy ina patient
with hypertrophic cardiomyopathy. Reduction in dia-
stolic asynchrony after verapamil, with greater homo-
geneity in the relative magnitude of rapid filling and
atrial systole (AS), is associated with improved global
rapid diastolic filling. Other abbreviations as in Fig- i ~
ure I. a(5
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Figure 4. Contribution of atrial systole to end-diastolic volume
plotted as a function of sector number before (Control) and during
verapamil therapy in the same three patients illustrated in Figure
3 (A, B, and C). Filling during atrial systole is more homogeneous
among sectors after verapamil. The contribution of atrial systole
to global end-diastolic volume, shown in the right portion of each
panel, is reduced by verapamil.
I, Fig. 3) and decreased the regional variation in filling
during atrial systole (Fig. 3 and 4), reflecting greater homo-
geneity in the relative contribution of rapid diastolic filling.
Although the magnitude of decrease in the regional variation
in filling volume during atrial systole by both sector analysis
and quadrant analysis was small (1 and 3%, respectively)
and did not exceed the reproducibility limits of these mea-
surements, the mean decrease in regional variation in time
to minimal volume of 10 ms approached the reproducibility
limit of this measurement (11 ms), and the mean decrease
in variation in time to peak filling rate of 14 ms exceeded
its reproducibility limit (12 ms), Among the 48 patients,
the decrease in regional asynchrony was greater than the
reproducibility limit in 2 I patients for variation in time to
minimal volume and in 23 patients for variation in time to
peak filling rate. VerapamiJ effects on global diastolic filling
and regional nonuniformity were not related to the presence
or severity of an outflow tract gradient.
Discussion
Regional functional nonuniformity in hypertrophic
cardiomyopathy. Left ventricular relaxation and filling are
impaired in many patients with hypertrophic cardio-
myopathy (1-6,12,13), and altered left ventricular diastolic
function contributes importantly to the clinical manifesta-
tions of the disease (27,40). Reduced rate and magnitude
of rapid diastolic filling arise from factors determining the
passive elastic properties of the left ventricle (7-1 I), such
as hypertrophy, fibrosis and cellular disorganization, and
also from factors affecting the dynamics of left ventricular
relaxation. Relaxation may be impaired in hypertrophic car-
diomyopathy on the basis of both inactivation-dependent
and load-dependent processes (41,42). Inactivation-depen-
dent mechanisms include ischemia (43,44) or possibly other
primary processes resulting in intracellular calcium ion over-
load, whereas load-dependent mechanisms might include
(among others) alterations in extent of fiber shortening (41),
reduced rate and extent of coronary blood flow (43,44) and
reduced wall tension at the onset of mitral valve opening
(42). Regional asynchrony or nonuniformity is another load-
dependent mechanism affecting global left ventricular re-
laxation (42), in which persistent interaction of contractile
elements into diastole leads to regional myocardial tension
prolongation, resulting in prolonged or incomplete (or in-
coordinate) ventricular relaxation. Previous models of myo-
cardial ischemia and clinical studies of coronary artery dis-
ease (14---24) have demonstrated the important influence of
temporal inhomogeneity throughout the left ventricle on
global abnormalities of ventricular relaxation and filling.
Regional asynchrony has been identified in patients with
hypertrophic cardiomyopathy (1,3) and such regional ab-
normalities have been implicated in the disturbances of global
diastolic function (42). However, neither the relation be-
tween regional asynchrony and impaired left ventricular fill-
ing nor the potential reversibility of regional asynchrony in
hypertrophic cardiomyopathy has been studied intensively.
In our investigation, we used radionuclide angiographic
techniques to evaluate regional and global left ventricular
function before and after verapamil therapy. Our data in-
dicate that significant systolic and diastolic asynchrony is
prevalent in patients with hypertrophic cardiomyopathy in
the absence of coronary artery disease, and that regional
diastolic asynchrony is related to regional variation in the
relative contributions of rapid diastolic filling and atrial sys-
tole to end-diastolic volume. This regional variation in the
timing and extent of rapid filling, in turn, relates to global
disturbances in the rate, timing and magnitude of left ven-
tricular filling, These data suggest that in many patients with
hypertrophic cardiomyopathy, as in patients with coronary
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artery disease, impaired global diastolic filling may result
at least in part from regional nonuniformity of left ventric-
ular systolic and diastolic function.
Factors contributing to regional nonuniformity. There
are several possible mechanisms that might contribute to
regional nonuniformity in hypertrophic cardiomyopathy.
These include heterogeneous myocardial hypertrophy (and
hence regionaldifferencesin wall stress during both systolic
and diastolic phases of the cardiac cycle), regional foci of
myocardial fibrosis, regionalvariation in the rate and extent
of coronary blood flow and regional myocardial ischemia
(or other primaryprocessesresultingin intracellularcalcium
overload). It is not possible to identify with certainty the
contributing factor or factors on the basis of the current
noninvasive information. Despitethis limitation,our results
underscore the role of regional nonuniformity as a load-
dependentdeterminantof left ventricularrelaxation and fill-
ing (42). Our data also indicate that factors other than hy-
pertrophy itself contribute to impaired regional diastolic
function, because one-third of patients manifested reduced
rapid filling in segments of the left ventricle that were not
greatly hypertrophied. These data support previous obser-
vations in hypertrophic cardiomyopathy of diastolic abnor-
malities in left ventricular regions of normal wall thickness
(45) and suggest either that the cardiomyopathic process
may exist in the absence of substantial hypertrophy, or that
excessive wall stress in regions without hypertrophy may
compromise myocardial function in these regions.
Effect of verapamil. Improvement in indexes of re-
gional left ventricular asynchrony and diastolic inhomoge-
neity during verapamil therapy suggest that dynamic, re-
versiblemechanisms, ratherthan fixed regional morphologic
abnormalities, must be responsible at least in part for re-
gional nonuniformity in hypertrophic cardiomyopathy. Ve-
rapamil efficacy in this context might reflect improved re-
gional relaxation stemming fromsalutary alterations in loading
conditions of the hypertrophied left ventricle, such as re-
duced end-systolicpressureand increasedend-diastolic vol-
ume (with no increase in end-diastolic pressure) (46-48).
Alternatively, verapamil has the potential to increase re-
gional coronary blood flow, which could act as a load-
dependent mechanism to potentiate the relaxation process
(41). In addition to these possible load-dependent effects,
verapamil may also enhance myocardial inactivation by re-
duction of intracellular calcium overload (either by direct
mechanisms or indirectly by amelioration of ischemia).
Reduction in regional diastolic nonuniformity during ve-
rapamiltreatmentwasassociatedwithenhancedglobal rapid
diastolic filling: the peak rate and extent of rapid filling
increased and the time to peak filling rate decreased. Pre-
vious data indicate that these changes in global diastolic
filling are clinically relevant and correlate with lesseningof
symptoms and objective improvement in exercise tolerance
during treatment with verapamil (27).
Conclusions. Our data demonstrate that asynchronous
and nonuniform regional systolic and diastolic function in
patients with hypertrophic cardiomyopathy, as in patients
with coronary artery disease, may contribute importantly to
impaired global left ventricular diastolic filling. The dy-
namic rather than fixed nature of these regional abnormal-
ities suggests that left ventricular nonuniformity does not
arise purely from irreversible alterations in left ventricular
regional morphology, but may also reflect potentially re-
versible regional variation in myocardial inactivation or load.
Although the precise mechanism responsible for regional
nonuniformity and its modulation by verapamil cannot be
determined from our data, our findings provide evidence
that the beneficial effects of verapamil on global left ven-
tricular diastolic function in hypertrophic cardiomyopathy
may be mediated by reduction in regional asynchrony.
We are grateful to Imogene Surrey for excellent secretarial assistance in
preparation of this manuscript.
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